Mitochondria play a prominent role in shaping intracellular calcium co
ncentration ([Ca2+](i)) transients in dorsal root ganglion neurons. Mi
tochondrial DNA polymerase is inhibited by antiviral compounds such as
2',3'-dideoxycytidine (ddC). Here, we test the hypothesis that ddC ca
n alter mitochondrially mediated Ca2+ buffering in neurons. Chronic tr
eatment of dorsal root ganglion cultures with ddC (7 mu M) lowered mit
ochondrial DNA levels and decreased the mitochondrially mediated compo
nent of depolarization-induced [Ca2+](i) transients. The inhibition in
creased in a time-dependent manner, reaching a maximum at 6 days. ddC
did not affect small, action potential-evoked, [Ca2+](i) transients th
at are predominantly buffered by Ca2+-ATPases, suggesting that ATP lev
els were not depleted. The drug did not inhibit whole-cell Ca2+ curren
ts, indicating that the Ca2+ load was not affected. Thus, ddC produces
a graded, time-dependent inhibition of mitochondrial function that is
reflected, in part, by a decrease in the direct buffering of Ca2+ by
mitochondria. This effect may contribute to the peripheral neuropathy
that results from ddC treatment. Furthermore, ddC promises to be a use
ful tool to study the role of mitochondria in [Ca2+](i) homeostasis an
d neurodegenerative processes.